Rubric Capital Management L.P. 13F annual report

Rubric Capital Management L.P. is an investment fund managing more than $3.38 trillion ran by Michael Nachmani. There are currently 66 companies in Mr. Nachmani’s portfolio. The largest investments include Teva Pharmaceutical Inds Ltd and Viatris, together worth $470 billion.

$3.38 trillion Assets Under Management (AUM)

As of 3rd May 2024, Rubric Capital Management L.P.’s top holding is 17,669,588 shares of Teva Pharmaceutical Inds Ltd currently worth over $249 billion and making up 7.4% of the portfolio value. In addition, the fund holds 18,442,093 shares of Viatris worth $220 billion, whose value grew 28.8% in the past six months. The third-largest holding is Roivant Sciences Ltd worth $211 billion and the next is Golar Lng worth $157 billion, with 6,506,757 shares owned.

Currently, Rubric Capital Management L.P.'s portfolio is worth at least $3.38 trillion. The total portfolio value may be much higher due to cash assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.

Careers at Rubric Capital Management L.P.

The Rubric Capital Management L.P. office and employees reside in New York, New York. According to the last 13-F report filed with the SEC, Michael Nachmani serves as the Chief Operating Officer at Rubric Capital Management L.P..

Recent trades

In the most recent 13F filing, Rubric Capital Management L.P. revealed that it had opened a new position in Ishares Bitcoin Tr and bought 1,722,497 shares worth $69.7 billion.

The investment fund also strengthened its position in Viatris by buying 5,192,093 additional shares. This makes their stake in Viatris total 18,442,093 shares worth $220 billion. Viatris soared 26.0% in the past year.

On the other hand, there are companies that Rubric Capital Management L.P. is getting rid of from its portfolio. Rubric Capital Management L.P. closed its position in Cameco on 10th May 2024. It sold the previously owned 2,523,540 shares for $100 billion. Michael Nachmani also disclosed a decreased stake in Teva Pharmaceutical Inds Ltd by approximately 0.1%. This leaves the value of the investment at $249 billion and 17,669,588 shares.

One of the largest hedge funds

The two most similar investment funds to Rubric Capital Management L.P. are Amg National Trust Bank and Horizon Investments. They manage $3.38 trillion and $3.38 trillion respectively.


Michael Nachmani investment strategy

Rubric Capital Management L.P.’s portfolio is diversified across 9 sectors. Currently, their heaviest sector is Health Care — making up 28.8% of the total portfolio value. The fund focuses on investments in the United States as 50.0% of the portfolio companies are based in the United States.

The majority of the companies in the fund’s portfolio are small-cap stocks. Stocks with a size of more than $100 million in market cap make up 5% of the total holdings value. On the other hand, large-cap stocks make up only 3.0% of the portfolio. The average market cap of the portfolio companies is close to $2.09 billion.

The complete list of Rubric Capital Management L.P. trades based on 13F SEC filings

These positions were updated on May 10th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.

Security Shares Owned Value Allocation
Teva Pharmaceutical Inds Ltd
7.00%
17,669,588
$249,317,887,000 7.37%
Viatris Inc.
39.19%
18,442,093
$220,198,590,000 6.51%
Roivant Sciences Ltd
90.48%
20,000,000
$210,800,000,000 6.23%
Golar Lng
No change
6,506,757
$156,552,573,000 4.63%
Bgc Group Inc
5.00%
19,000,000
$147,630,000,000 4.37%
Mr. Cooper Group Inc
22.72%
1,518,773
$118,388,355,000 3.50%
QuidelOrtho Corporation
709.65%
2,400,000
$115,056,000,000 3.40%
Fluor Corp New
9.26%
2,600,000
$109,928,000,000 3.25%
Cameco Corp.
Closed
2,523,540
$100,033,126,000
Vistra Corp
101.60%
1,213,998
$84,554,961,000 2.50%
Constellium SE
85.76%
3,630,347
$80,266,972,000 2.37%
Pactiv Evergreen Inc.
10.83%
5,541,393
$79,352,748,000 2.35%
Mativ Holdings Inc
No change
4,000,000
$75,000,000,000 2.22%
Arcutis Biotherapeutics Inc
49.17%
7,510,000
$74,424,100,000 2.20%
Heron Therapeutics Inc
No change
26,713,503
$73,996,403,000 2.19%
Collegium Pharmaceutical Inc
42.24%
1,834,027
$71,196,928,000 2.11%
Renew Energy Global Plc
18.33%
11,711,700
$70,270,200,000 2.08%
Ishares Bitcoin Tr
Opened
1,722,497
$69,709,454,000 2.06%
ANI Pharmaceuticals Inc
13.17%
958,533
$66,263,386,000 1.96%
Liberty Global Ltd
Opened
5,738,644
$98,461,028,000 2.91%
Hertz Global Holdings Inc.
Closed
5,165,254
$63,274,362,000
Dole plc
37.39%
5,141,388
$61,336,759,000 1.81%
Stratasys Ltd
454.56%
5,050,000
$58,681,000,000 1.74%
Amneal Pharmaceuticals Inc
137.10%
9,541,948
$57,824,205,000 1.71%
Ncr Voyix Corporation
Opened
4,546,081
$57,417,003,000 1.70%
Orthofix Med Inc
6.71%
3,665,000
$53,215,800,000 1.57%
NRG Energy Inc.
Closed
1,318,020
$50,770,130,000
Adeia Inc
No change
4,640,009
$50,668,898,000 1.50%
Xperi Inc
No change
4,043,744
$48,767,553,000 1.44%
Mereo BioPharma Group plc
16.67%
13,552,997
$44,724,890,000 1.32%
AAR Corp.
40.98%
725,000
$43,405,750,000 1.28%
Kiniksa Pharmaceuticals Ltd
28.64%
2,196,009
$43,327,258,000 1.28%
Playa Hotels & Resorts Nv
20.01%
4,155,840
$40,311,648,000 1.19%
Extreme Networks Inc.
Opened
3,450,000
$39,813,000,000 1.18%
Hollysys Automation Tchngy L
Closed
1,941,237
$38,514,142,000
Dave & Busters Entmt Inc
Opened
598,503
$37,466,288,000 1.11%
Zymeworks Inc
31.08%
3,475,384
$36,561,040,000 1.08%
Atmus Filtration Technologie
Opened
1,132,056
$36,508,806,000 1.08%
Adaptive Biotechnologies Cor
Opened
10,500,000
$33,705,000,000 1.00%
Koppers Holdings Inc
49.70%
572,658
$31,593,542,000 0.93%
Magnite Inc
Closed
4,000,000
$30,160,000,000
Transalta Corp.
6.41%
4,687,158
$30,138,426,000 0.89%
Par Pac Holdings Inc
60.84%
772,384
$28,624,551,000 0.85%
Cannae Holdings Inc
Opened
1,214,217
$27,004,186,000 0.80%
Schrodinger, Inc.
Opened
998,276
$26,953,452,000 0.80%
Avis Budget Group Inc
Opened
215,092
$26,340,166,000 0.78%
Coherus Biosciences Inc
Opened
10,400,000
$24,856,000,000 0.73%
Riskified Ltd.
159.19%
4,173,636
$22,579,371,000 0.67%
SpringWorks Therapeutics, Inc.
Opened
426,768
$21,005,521,000 0.62%
Ftai Infrastructure Inc
No change
3,193,530
$20,055,368,000 0.59%
Nuvalent Inc
Opened
261,874
$19,664,119,000 0.58%
Trevi Therapeutics, Inc.
2.12%
5,564,123
$19,196,224,000 0.57%
AdaptHealth Corp.
Closed
1,961,199
$17,846,911,000
scPharmaceuticals Inc
29.92%
3,525,000
$17,695,500,000 0.52%
Ovid Therapeutics Inc
2.39%
5,315,969
$16,213,705,000 0.48%
Omniab Inc
No change
2,850,588
$15,450,187,000 0.46%
GoodRx Holdings, Inc.
Opened
2,117,054
$15,031,083,000 0.44%
Madison Square Grdn Sprt Cor
Closed
83,512
$14,723,166,000
Pacira BioSciences Inc
Closed
459,637
$14,101,663,000
Ardelyx Inc
27.34%
1,816,585
$13,261,071,000 0.39%
Revance Therapeutics Inc
66.05%
2,656,847
$13,071,687,000 0.39%
Sutro Biopharma Inc
Closed
3,344,810
$11,606,491,000
Cullinan Oncology, LLC
No change
626,929
$10,682,870,000 0.32%
Clear Channel Outdoor Hldgs
Closed
6,705,943
$10,595,390,000
Werewolf Therapeutics Inc
16.24%
1,621,034
$10,504,300,000 0.31%
Pediatrix Medical Group Inc
Opened
908,600
$9,113,258,000 0.27%
Telesat Corp
No change
959,764
$8,177,189,000 0.24%
MagnaChip Semiconductor Corp
Closed
967,867
$8,042,975,000
Playstudios Inc
20.78%
2,368,777
$6,585,200,000 0.19%
Ars Pharmaceuticals Inc
No change
639,203
$6,532,655,000 0.19%
Opko Health Inc
Opened
4,935,814
$5,922,977,000 0.18%
Protagonist Therapeutics Inc
Opened
198,059
$5,729,847,000 0.17%
Carpenter Technology Corp.
Opened
78,661
$5,617,969,000 0.17%
Bicycle Therapeutics plc
No change
205,423
$5,115,033,000 0.15%
Conduent Inc
Closed
834,660
$2,904,617,000
TherapeuticsMD, Inc.
No change
1,192,191
$2,730,117,000 0.08%
Xeris Biopharma Holdings Inc
Opened
310,959
$687,219,000 0.02%
Vincerx Pharma Inc
67.02%
116,873
$591,377,000 0.02%
No transactions found
Showing first 500 out of 78 holdings